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Emerging evidence suggests that, in addition to neu­
ronal inputs, growth factors of glial origin are also 
important in the control of mammalian puberty via a 
cell-cell interaction that ultimately affects the neu­
rons that release gonadotropin-releasing hormone 
(GnRH), a neurohormone controlling sexual devel­
opment. Among these growth factors, transforming 
growth factor-a (TGFa) appears to be one of the 
physiologic components that controls the onset of 
female puberty by affecting GnRH neuronal activity 
in a glia-mediated autocrine/paracrine manner. Spe­
cifically, TGFa induces glia to produce bioactive 
substances, such as prostaglandin E2 (pGE2). In turn, 
PGE2 directly acts on GnRH neurons to stimulate the 
T he onset of mammalian female puberty depends on the enhanced secretory activity of a specialized group of neurons that produce gonadotropin-releasing hor­mone (GnRH). a key neurohonnone for sexual maturation and reproductive function. The regula­
tion of GnRH neuronal function has been a focal issue for 
understanding the cellular and molecular mechanisms controlling 
sexual development and reproductive biology. It is believed that 
neuron to neuron trans synaptic inputs. both excitatory (Brann and 
Mahesh. 1994; Crowley et al 1995) and inhibitory (Terasawa, 
1995). contribute to the regulation of GnRH secretory activity. A 
combination of a decrease in inhibitory tone and an increase in 
excitatory input has been generally considered to bring about the 
initiation of puberty. The main excitatory inputs include neuronal 
systems that utilize norepinephrine (Ramirez et aI1984), neuropep­
tide Y (Crowley et at 1995). and excitatory amino acids (Ojeda. 
1991; Brann and Mahesh. 1994; Plant. 1994). The inhibitory 
components, on the other hand, are y-aminobutyric acid (Masotto 
and Negro-Vilar. 1987; Terasawa. 1995) and opioid peptides 
(Bhanot and Wilkinson, 1983). 
Although this neuronal regulation of the GnRH neuronal net­
work is well-documented. recent studies have raised the intriguing 
possibility that glial cells may also play a role in the control of 
GnRH neuronal activity (Ojeda and Ma, 1995). Anatomical studies 
revealed that the glial ensheathment of GnRH cell bodies in 
primates is prominent, as glial processes surround the GnRH cells 
(Witkin et aI1991). Such a structural relationship suggests a direct 
glial influence on GnRH neuronal activity. This hypothesis is 
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release of GnRH. Furthermore, the neuregulin of 
glial origin neu differentiation factor (NDF) was 
found to facilitate the action of TGFa, suggesting 
that other growth factors may exert their biologic 
effects on GnRH neuronal function via a glia/neuron 
interaction. Another indication that glial cells may 
be involved in the regulation of neuroendocrine 
function is the presence of estrogen receptors on 
hypothalamic astrocytes. Thus, region-specific glial 
cells appear to play an integral role in the regulation 
of neuroendocrine function. Key words: astrocytesl 
growth factorslreceptorslGnRH. Journal of Investigative Der­
matology Symposium Proceedings 2:19-22, 1997 
further supported by the evidence that glial cells produce a variety 
ofbioactive molecules and growth factors able to affect the activity 
of GnRH neurons. Furthennore, glial apposition to GnRH nerve 
terminals in the median eminence of the hypothalamus is yet 
another specialized structural feature in both rats and primates. The 
predominant cells in the median eminence are astrocytes and 
modified ependymal glia known as tanycytes (Kobayashi and 
Matsui, 1969). Interestingly, these specialized glial cells that line 
the wall of the third ventricle send their processes toward the 
endothelial wall of the portal blood vasculature, neighboring the 
GnRH nerve terminals (Kobayashi and Matsui, 1969; Kozlowski 
and Coates. 1985). More intriguingly, sex steroids appear to 
modulate this structural arrangement as demonstrated by the 
finding that the space between the GnRH-nerve terminals and the 
basal lamina of the portal vasculature decreases after ovariectomy, 
presumably due to retraction of the glial cells. These structural 
changes may lead to an increase in the access of GnRH terminals to 
the portal vessels. The evidence that about 50% of glial cells in the 
median eminence have estrogen receptors (Langub and Watson, 
1992) further supports the notion that a direct action of estrogen on 
glial cells is region-specific (Ma et ai, 1994a). Because glial­
neuronal synaptoid specializations are common structural features 
in the median eminence (Kobayashi and Matsui, 1969), the concept 
of a direct glial involvement in the control of GnRH release via 
cell-cell interactions with GnRH nerve terminals was proposed. In 
this article, we will discuss some recent results obtained by our 
laboratory that underscore the emerging role of glial cells in the 
regulation of GnRH neuronal function. 
We demonstrated that glia-derived transforming growth factor 
alpha (TGFa), a mitogenic polypeptide member of the epidennal 
growth factor (EGF) family (Derynck, 1988; Carpenter and Cohen, 
1990; Massague, 1990), plays an important role in the glia-neuron­
mediated control ofGnRH secretory activity (Ma et a11992, 1994a, 
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Figure 1. A simplified schematic illustration of the postulated 
control ofGnRH neuronal function. (1) Transsynaptic inputs regulate 
GnRH release. For detailed description, see text. (2)-(3) Glial-derived 
TGFa and other related growth factors stimulate the secretion of neuroac­
tive substances (i.e .. PGE2) in a paracrine/autocrine fashion. (4) Neuroac­
tive substances act on GnRH neurons to enhance secretion. See text for 
further description. 
1994b, 1994c, 1994d; Ojeda, 1994) (see Fig 1). Other distant 
members of the EGF family, neuregulins of glial origin-including 
heregulin (Holmes et ai, 1992) and neu differentiation factor (Wen 
et ai, 1992), the alternatively spliced products from a single gene 
(Wen et ai, 1992; Marchionni et ai, 1993; )-appear to be also 
involved in the regulation of GnRH release via a mechanism by 
which neu differentiation factor facilitates the action of TGFa (YJ 
Ma, DF Hill, M Costa, SR Ojeda, unpublished observation). Like 
other members of the EGF family, TGFa is synthesized as a 
transmembrane precursor. It is important to note that this precursor 
is able to interact with neighboring cells endowed with its recep­
tors, without the need of releasing the mature peptide. This type of 
cellular action is designated "juxtacrine" (Massague, 1990) and 
represents an additional cellular signaling mechanism of mem­
brane-anchored growth factors in the central nervous system. 
The biologic actions of TGFa, like other members of the EGF 
family, are initiated by binding to a family of membrane-spanning 
receptors with protein kinase activity for cellular signaling 
(Schechter et ai, 1985; Carpenter, 1987; Kraus et ai, 1989; Plowman 
et ai, 1990, 1993). The receptor for TGFa (as well as EGF, 
amphiregulins, and others) is a 170-kDa glycosylated protein 
known as the EGF receptor (EGFR) that has an extracellular 
domain containing the amino acid motif essential for specific ligand 
recognition, a single transmembrane domain, and an intracellular 
enzyme catalytic element containing the tyrosine kinase activity. 
Other EGFR-related members (encoded by different proto-onco­
genes) including HER-2 (neu) receptor (Karunagaran et ai, 1996), 
HER-3 (named ERBB-3) (Kraus ef aI, 1989; Plowman et ai, 1990), 
and HER-4 (Plowman et ai, 1993) also have similar structural 
features. These EGFR congeners, however, do not directly bind to 
TGFa, EGF, and amphiregulin, but instead recognize other mem­
bers of the EGF family. Recent studies have suggested that the 
heterodimers (HER-2IHER-3 or HER-2IHER-4) and homodimer 
(HER-4/HER-4) are the functional receptor units required for the 
signal transduction of neuregulins (for review see Lemke, 1996). 
Furthermore, HER-2 can be transmodulated by the activation of 
EGFR (Stem and Kamps, 1988), suggesting interactions between 
EGFR and HER-2. This view is supported by the observation that 
HER-2 is able to function as an auxiliary component that enhances 
the affinity of EGFR by stabilizing dimerization of the receptor 
(Karunagaran et ai, 1996). 
In our studies of both rats (Ma et ai, 1992) and nonhuman 
primates (Ma I't ai, 1994b), we found that the TGFa gene and its 
protein product are predominantly expressed in astroglial cells of 
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certain hypothalamic nuclei involved in the control of GnRH 
neuronal function (Ma et ai, 1992), such as the suprachiasmatic and 
arcuate nucleus. Both TGFa mRNA and protein levels are also 
abundant in tanycytes and glial cells of the median eminence, and 
the levels are significantly elevated around the time of puberty (Ma 
et ai, 1992, 1994b). Furthermore, EGFR in the median eminence is 
colocalized with TGFa (Ma et aI, 1994d), and-at least in monkeys 
(Ma et ai, 1994b )-its developmental expression profile parallels 
that of TGFa, indicating the involvement of the glia-derived 
growth factor and its receptor in neuroendocrine regulation. That 
TGFa may be involved in the control of GnRH neuronal activity 
was demonstrated by the fmding that TGFa is able to stimulate the 
release of GnRH from median eminence fragments in a dose­
response-related manner (Ojeda et ai, 1990). Subsequent studies 
further supported the notion that a TGFa/EGFR system contrib­
utes, at least in part, to the normal initiation of mammalian female 
puberty because overexpression of TGFa in transgenic mice in­
duced precocious puberty (Ma et ai, 1994c). In contrast, blockade of 
EGFR tyrosine kinase activity by RG-50864 (Yaish et ai, 1988) 
targeted to the median eminence resulted in a delayed onset of 
puberty (Ma et ai, 1992), suggesting that activation of the EGFR­
mediated signaling pathway is critical for the initiation of reproduc­
tive competence. Our most recent evidence (YJ Ma, DF Hill, M 
Costa, SR Ojeda, unpublished data) show that glia-derived neu 
differentiation factor is able to enhance the stimulatory action of 
TGFa on GnRH release via activation of an HER-2IHER-4 
receptor complex, indicating that other members of the EGF family 
may also be involved in the process of sexual development. This 
view is further supported by the evidence (YJ Ma, DF Hill, M 
Costa, SR Ojeda, unpublished observation) that disruption of 
HER-2 synthesis via an anti-sense oligonucleotide attenuated the 
stimulatory effect of TGFa on GnRH release. 
The effect of TGFa on GnRH secretion does not appear to be 
direct, as GnRH neurons do not express EGFR. The GnRH 
terminals in the median eminence, however, are in close association 
with glial cells that express TGFa and EGFR (Ma et ai, 1992, 
1994d), suggesting that these glial cells mediate the effect ofTGFa. 
This view is supported by the recent findings (Ma et ai, 1997) that 
isolated hypothalamic astrocytes respond to TGFa with the release 
of prostaglandin E2 (PGE2), a bioactive substance that stimulates 
GnRH release. That PGE2 (although one cannot rule out other 
bioactive substances), in tum, acts on GnRH neurons to stimulate 
the release of GnRH is indicated by the ability of conditioned 
medium from hypothalamic astrocytes treated with TGFa to 
enhance GnRH release from the GnRH-producing cell line GT1-1. 
These cells express no EGFR and are untesponsive to TGFa itself 
(Voigt et aI, 1996). Moreover, blockade of PGE2 action by immuno­
neutralization in the conditioned medium abolished the effect of the 
conditioned medium on GnRH release (Ma et ai, 1997). 
The biologic actions ofPGE2 are initiated via the activation of its 
receptors, including at least four subtypes known as EPl, EP2, EP3, 
and EP4 (Sugimoto et ai, 1992; Honda ef ai, 1993; Watabe et ai, 
1993). Activation of EPI leads to increased calcium flux, whereas 
EP2 enhances and EP3 attenuates adenylate cyclase activity, sug­
gesting that the diversity of actions of PGE2 in different circum­
stances may depend on the type of PGE2 receptors expressed. By 
ribonuclease protection assay, we observed the presence of mRNAs 
encoding EP1 and EP3 in the immortalized GnRH neuronal GT1-1 
cell line. Utilizing ill situ hybridization combined with immunocy­
tochemistry, we further observed that EPI mRNA is expressed by 
GnRH neurons in mouse hypothalamus (F Rage, BJ Lee, YJ Ma, 
SR Ojeda, unpublished data). These studies provided cellular and 
molecular evidence supporting the view that GnRH secretion is 
regulated by biomolecules produced by glial cells in response to the 
action of TGFa. 
The importance of glial-neuronal interactions in the regulation of 
GnRH neuronal activity is further indicated by the finding that 
glutamic acid, a major excitatory amino acid neurotransmitter in 
the neuroendocrine brain (van den Pol et ai, 1990), is released from 
astrocytes and affects neuronal activity (ParpuTa et ai, 1994). We 
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found that glutamate increases TGFa mRNA expression in hypo­
thalamic astroglia via activation of metabotropic glutamate recep­
tors located on the astrocytes.1 Thus, specific metabotropic gluta­
mate receptor subtypes may be involved in the process by which 
excitatory amino acids control glial TGFa production and, hence, 
facilitate GnRH release. Other excitatory neurotransmitters were 
also shown to influence glial function (Chiu and Kriegler, 1994; 
Glowinski et ai, 1994). 
It is well-documented that estradiol is important in regulating 
GnRH neuronal function (for review, see Ojeda and Urbanski, 
1994; Kalra, 1986). The action of estradiol on GnRH release, 
however, is indirect, as GnRH neurons themselves do not contain 
detectable estrogen receptors (Shivers et ai, 1983), indicating that 
other cell types expressing the receptors mediate this effect. That 
hypothalamic astrocytes, in addition to other neurons, may con­
tribute to mediating the action of estradiol is indicated by the 
finding that estrogen receptor mRNA was detected in hypotha­
lamic astrocytes (Ma et ai, 1994a). Estradiol is able to enhance 
TGFa gene expression in hypothalamic, but not cerebellar (Le., 
non-neuroendocrine), astrocytes (Ma et ai, 1994a). Moreover, the 
culture medium of astrocytes exposed to estradiol increases PGE2 
receptor EP1 gene expression in GT1-1 cells. No change in EP1 
mRNA levels was observed, however, in GT1-1 cells directly 
treated with estradiol (F Rage, BJ Lee, YJ Ma, SR Ojeda, 
unpublished data). These findings suggest that astrocytes of the 
neuroendocrine brain are indeed able to mediate the effect of 
gonadal steriods on LnRH release. 
In summary, mammalian puberty is initiated within the brain by 
multiple but well-coordinated events that ultimately affect the 
activity of the GnRH neuronal network. These events include: (i) 
an increase in trans synaptic excitatory inputs such as excitatory 
amino acids, norepinephrine, and neuropeptide Y; (ii) a decrease in 
the trans synaptic y-aminobutyric acid-inhibitory regulation, and 
(iii) increased glial production of growth factors able to stimulate 
the production of neuroactive substances, such as prostaglandins. It 
appears that members of the EGF family, such as TGFa and its 
distant relatives neuregulins, are factors contributing to this glial 
involvement. Finally, it is of great interest to determine whether 
these glial influences are also essential for the regulation and 
maintenance of normal reproductive function during adulthood. 
Future experiments are needed to address this important issue. 
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